Creative Medical Technology Holdings, Inc. Common Stock CELZ
Key Stats
- Today's Range
- $1.19 – $1.28
- 50-Day Range
- $0.62 – $4.72
- 52-Week Range
- $0.62 – $6.25
- Volume
- 679K shs
- Average Volume
- 13.20 million shs
- Market Cap
- $8.04 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.25%
- Days to Cover
- 1.00
About Creative Medical Technology Holdings, Inc. Common Stock
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
Related Stocks
Compare head-to-head: CELZ vs AMGN·CELZ vs HALO·CELZ vs KYMR·CELZ vs RGEN
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.